Literature DB >> 15661863

Differential estrogen receptor expression in autoimmune myasthenia gravis.

Patrice Nancy1, Sonia Berrih-Aknin.   

Abstract

Myasthenia gravis (MG) is an autoimmune disease associated with thymic hyperplasia and is much more prevalent in women than men. In this study we investigated potential changes in estrogen receptor (ER) expression in thymic hyperplasia. We first quantified by real-time PCR the relative expression of ER alpha and ER beta in normal thymus and found that the ER beta to ER alpha ratio was inverted in thymocytes (8.6 +/- 1.2), compared with thymic epithelial cells (0.18 +/- 0.05). The ER transcript number gradually decreased in thymic epithelial cells during culture, indicating that the thymic environment influences ER expression. CD4+ helper T cells expressed higher level of ERs, compared with CD8+ cells, as assessed by flow cytometry in thymocytes and peripheral blood mononuclear cells. In MG patients, we found an increased expression of ER alpha on thymocytes and both ERs on T cells from peripheral blood mononuclear cells, indicating that the signals provided by thymic and peripheral microenvironments are distinct. Finally, activation of normal thymocytes by proinflammatory cytokines induced increased expression of ERs especially in the CD4+ subset, suggesting that an excess of proinflammatory cytokines could explain the increase of ERs expression on MG lymphocytes. The dysregulation of ER expression in MG lymphocytes could affect the maintenance of the homeostatic conditions and might influence the progression of the autoimmune response.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15661863      PMCID: PMC1839841          DOI: 10.1210/en.2004-1003

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  56 in total

1.  A susceptibility region for myasthenia gravis extending into the HLA-class I sector telomeric to HLA-C.

Authors:  M Janer; A Cowland; J Picard; D Campbell; P Pontarotti; J Newsom-Davis; M Bunce; K Welsh; A Demaine; A G Wilson; N Willcox
Journal:  Hum Immunol       Date:  1999-09       Impact factor: 2.850

2.  The role of the Fas/Fas ligand system in estrogen-induced thymic alteration.

Authors:  G Mor; A Muñoz; R Redlinger; I Silva; J Song; C Lim; F Kohen
Journal:  Am J Reprod Immunol       Date:  2001-10       Impact factor: 3.886

Review 3.  Sex hormones as immunomodulators in health and disease.

Authors:  D Verthelyi
Journal:  Int Immunopharmacol       Date:  2001-06       Impact factor: 4.932

4.  Estrogen receptor alpha is necessary in thymic development and estradiol-induced thymic alterations.

Authors:  J E Staples; T A Gasiewicz; N C Fiore; D B Lubahn; K S Korach; A E Silverstone
Journal:  J Immunol       Date:  1999-10-15       Impact factor: 5.422

5.  Acetylcholinesterase activity and menstrual remissions in myasthenia gravis.

Authors:  N Vijayan; V K Vijayan; P M Dreyfus
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-11       Impact factor: 10.154

6.  Age and sex associations of 40 autoimmune diseases.

Authors:  P B Beeson
Journal:  Am J Med       Date:  1994-05       Impact factor: 4.965

7.  Specific estrogen binding sites in human lymphoid cells and thymic cells.

Authors:  L Danel; G Souweine; J C Monier; S Saez
Journal:  J Steroid Biochem       Date:  1983-05       Impact factor: 4.292

8.  Estrogen receptor (ER)-beta reduces ERalpha-regulated gene transcription, supporting a "ying yang" relationship between ERalpha and ERbeta in mice.

Authors:  Marie K Lindberg; Sofia Movérare; Stanko Skrtic; Hui Gao; Karin Dahlman-Wright; Jan-Ake Gustafsson; Claes Ohlsson
Journal:  Mol Endocrinol       Date:  2003-02

9.  Localization of estrogen receptors and estrogen receptor-mRNA in female mouse thymus.

Authors:  I Kawashima; K Seiki; K Sakabe; S Ihara; A Akatsuka; Y Katsumata
Journal:  Thymus       Date:  1992-09

10.  Steroid receptors in the myasthenic thymus.

Authors:  M M Brentani; V R Martins; P E Marchiori
Journal:  Braz J Med Biol Res       Date:  1987       Impact factor: 2.590

View more
  18 in total

1.  Oestradiol potentiates the suppressive function of human CD4 CD25 regulatory T cells by promoting their proliferation.

Authors:  G Aleph Prieto; Yvonne Rosenstein
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

2.  Intercommunication between the neuroendocrine and immune systems: focus on myasthenia gravis.

Authors:  Jacqueline Mays; Cherié L Butts
Journal:  Neuroimmunomodulation       Date:  2011-09-22       Impact factor: 2.492

Review 3.  Hormonal control of T-cell development in health and disease.

Authors:  Wilson Savino; Daniella Arêas Mendes-da-Cruz; Ailin Lepletier; Mireille Dardenne
Journal:  Nat Rev Endocrinol       Date:  2015-10-06       Impact factor: 43.330

4.  Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.

Authors:  Peter K Gregersen; Roman Kosoy; Annette T Lee; Janine Lamb; Jon Sussman; David McKee; Kim R Simpfendorfer; Ritva Pirskanen-Matell; Frederik Piehl; Qiang Pan-Hammarstrom; Jan J G M Verschuuren; Maarten J Titulaer; Erik H Niks; Alexander Marx; Philipp Ströbel; Björn Tackenberg; Michael Pütz; Angelina Maniaol; Ahmed Elsais; Chantal Tallaksen; Hanne F Harbo; Benedicte A Lie; Soumya Raychaudhuri; Paul I W de Bakker; Arthur Melms; Henri-Jean Garchon; Nicholas Willcox; Lennart Hammarstrom; Michael F Seldin
Journal:  Ann Neurol       Date:  2012-10-10       Impact factor: 10.422

5.  Immune cell-mediated neuroprotection is independent of estrogen action through estrogen receptor-alpha.

Authors:  Junping Xin; Keith N Fargo; Lisa Tanzer; Virginia M Sanders; Kathryn J Jones
Journal:  Metab Brain Dis       Date:  2012-03       Impact factor: 3.584

Review 6.  Review: Male systemic lupus erythematosus: a review of sex disparities in this disease.

Authors:  L-J Lu; D J Wallace; M L Ishimori; R H Scofield; M H Weisman
Journal:  Lupus       Date:  2009-11-27       Impact factor: 2.911

7.  Estrogen-mediated downregulation of AIRE influences sexual dimorphism in autoimmune diseases.

Authors:  Nadine Dragin; Jacky Bismuth; Géraldine Cizeron-Clairac; Maria Grazia Biferi; Claire Berthault; Alain Serraf; Rémi Nottin; David Klatzmann; Ana Cumano; Martine Barkats; Rozen Le Panse; Sonia Berrih-Aknin
Journal:  J Clin Invest       Date:  2016-03-21       Impact factor: 14.808

8.  The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis.

Authors:  Amel Meraouna; Geraldine Cizeron-Clairac; Rozen Le Panse; Jacky Bismuth; Frederique Truffault; Chantal Tallaksen; Sonia Berrih-Aknin
Journal:  Blood       Date:  2006-03-16       Impact factor: 22.113

Review 9.  Research advancement in immunopathogenesis of myasthenia gravis.

Authors:  Sha Huang; Li-Ming Tan
Journal:  Neurosci Bull       Date:  2010-02       Impact factor: 5.203

10.  Prioritizing genes of potential relevance to diseases affected by sex hormones: an example of myasthenia gravis.

Authors:  Mandeep Kaur; Sebastian Schmeier; Cameron R MacPherson; Oliver Hofmann; Winston A Hide; Stephen Taylor; Nick Willcox; Vladimir B Bajic
Journal:  BMC Genomics       Date:  2008-10-13       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.